Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders

Author:

Chen Pei-Hao123ORCID,Cheng Shih-Jung124,Lin Hui-Chi1,Lee Chuo-Yu125,Chou Chih-Ho67ORCID

Affiliation:

1. Department of Neurology, MacKay Memorial Hospital, Taipei, Taiwan

2. Department of Medicine, Mackay Medical College, New Taipei City, Taiwan

3. Graduate Institute of Mechanical and Electrical Engineering, National Taipei University of Technology, Taipei, Taiwan

4. Department of Physical Therapy and Assistive Technology, National Yang-Ming University, Taipei, Taiwan

5. Graduate Institute of Chemistry, Tamkang University, New Taipei City, Taiwan

6. Department of Neurology, Chi-Mei Medical Center, Tainan, Taiwan

7. Chia Nan University of Pharmacy and Science, Tainan, Taiwan

Abstract

Objective. Mild cognitive impairment (MCI) is a transitional state between normal aging and early dementia. It has a heterogeneous etiology and clinical course. This study aimed to examine the factors associated with the progression of MCI in different types of dementia disorders.Method. A retrospective, longitudinal, observational study of outpatients with MCI was conducted at a medical center in northern Taiwan. Patient medical records were reviewed, and risk factors were analyzed by multivariate analysis.Results. Among 279 patients with MCI, 163 (58.4%), 68 (24.4%), and 48 (17.2%) were diagnosed with Alzheimer’s disease, vascular cognitive impairment, and Lewy body diseases, respectively. During the observation period, 37.2% of patients progressed to dementia. Older age and a higher Clinical Dementia Rating Scale-Sum of Boxes were associated with the risk of progression. Hyperlipidemia was associated with a decreased risk. Converters were more likely to receive an antidementia prescription.Conclusion. Our study suggests the importance of comprehensive clinical profiling, risk factor assessment, and detailed drug history evaluations in improving our understanding and management of dementia subtypes.

Publisher

Hindawi Limited

Subject

Clinical Neurology,Neurology,General Medicine,Neuropsychology and Physiological Psychology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3